
A cancer caregiver shares how she provided support for both her daughter and mother-in-law who were being treated for breast cancer at the same time, and what she learned from those experiences.

A cancer caregiver shares how she provided support for both her daughter and mother-in-law who were being treated for breast cancer at the same time, and what she learned from those experiences.

The US Preventive Services Task Force now recommends lowering the age and smoking history requirements for people to receive annual lung cancer screening.

Mindfulness practices have been associated with improved mental health outcomes in patients with cancer. Here, an expert shares tips on how patients can strengthen their “mindfulness muscle.”

The combination of Cabometyx (cabozantinib) plus Opdivo (nivolumab) “is certainly going to become one of the new standards of care” for the treatment of advanced renal cell carcinoma now that the regimen is approved, according to an expert from the Dana-Farber Cancer Institute.

Nearly one year ago to the day, 24-year-old Nina Luker was completely blindsided by a diagnosis of non-Hodgkin lymphoma. But after powering through treatments in the thick of the COVID-19 pandemic, Luker is now cancer-free and offering advice to those who may be looking for ways to help their loved ones through difficult times of their own.

A cancer survivor explains how in difficult times — such as living amid a pandemic or receiving treatment for cancer — just getting out of bed in the morning is a sign of bravery and magnificence.

With more than 4 million breast cancer survivors in the U.S., survivorship care and understanding what happens to patients after surviving is of the utmost importance. An expert explains some side effects survivors may experience and treatments to help.

If patients were receiving Tecentriq for prior platinum-based treated metastatic urothelial carcinoma, they should discuss next best steps with their health care providers.

On social media, CURE® recently asked its readers to share if they have experienced cancer-related fatigue and how they have dealt with it.

In honor of International Women’s Day, CURE® compiled some recent news and updates in women’s cancers that patients, survivors and caregivers may have missed.

A breast cancer survivor who opted for a unilateral mastectomy advises people to look at all treatment and risk reduction options when first diagnosed with breast cancer so they can avoid any regrets years later.

More than half of the deaths assessed in this study were related to non-cancer-related causes such as cardiovascular disease compared with cancer-related causes, which may reflect a need for risk factor management for heart disease during survivorship.

A roundup of some of the latest news and updates for patients with lung cancer from CURE®.

A survivor takes a closer look at the trouble with using the phrase “cancer-free” when discussing the disease with friends and family.

In honor of Colorectal Cancer Awareness Month, CURE® compiled some recent colorectal cancer news and updates patients and survivors may have missed.

As her seven-year cancerversary approaches, one patient with metastatic breast cancer shares why she is grateful to be a 'mutant'.

A roundup of some of the latest news and updates for patients with breast cancer from CURE®

This accelerated FDA approval is the first CAR T-cell therapy approved for the treatment of patients with indolent follicular lymphoma.

Last week, the Food and Drug Administration (FDA) was scheduled to make a decision on whether or not they would approve oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The agency decided not to approve the regimen, and issued a complete response letter outlining why.

Merck – the manufacturer of Keytruda (pembrolizumab) – is pulling the immunotherapy drug’s indication for patients with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy and one or more prior line of therapy.

A pancreatic cancer survivor shares why he writes about his journey and encourages other patients and survivors to do the same.

From President Biden convening a bipartisan meeting to discuss cancer treatments and research to a 5-year-old patient with hepatoblastoma asking for donations to a local food bank instead of presents for her birthday, here’s what’s happening in the cancer space this week.

The International Association for the Study of Lung Cancer recently joined more than 100 cancer centers and organizations in urging leading public health officials to prioritize administering the COVID-19 vaccine to cancer survivors and patients undergoing treatment for the disease.

While it is important to educate oneself after receiving a diagnosis of cancer, it’s also critical to know when to step away and find a balance between cancer and life, according to Diane Zipursky-Quale.

Having an exercise professional in chemotherapy infusion suites could significantly benefit patients with cancer and help improve health-related outcomes such as fatigue, according to recent study results.

An ovarian cancer survivor shares that although she’s been frustrated and mad about a recent recurrence in her lymph nodes, she still celebrates the life that she’s been blessed with.

This week on the “CURE® Talks Cancer” podcast, to kick off Colorectal Cancer Awareness Month, we spoke with colon cancer survivor April Schack about what it was like to be diagnosed at age 36 and how she’s working with Fight CRC on a new campaign that aims to raise awareness about the disease, so that no one has to go through what she did.

Women with a history of depression had higher rates of cancer-related fatigue, according to recent study results.

This approval expands a previous accelerated approval of the drug in 2018, allowing it for use in patients with brain metastases.

Patients treated with Imbruvica plus TG-1101 had an overall response rate of 83% compared with 65% in those treated with Imbruvica alone.